Anson focuses on patent prosecution matters in the health care, chemical, and life sciences industries. He is experienced in drafting and prosecuting US and foreign patent applications as well as conducting freedom-to-operate and patentability analyses and due diligence reviews. Anson also assists clients with patent portfolio management. His clients have included commercial entities, academic institutions, and nonprofit organizations.

Before rejoining Mintz, Anson served in increasingly senior patent roles at a biotechnology company, most recently as a patent counselor. He led global patent prosecution strategies involving multiple therapeutic areas, compositions, methods, and treatments. He also evaluated intellectual property risks and opportunities for internal and competitor technologies and advised management and research teams on patent strategy and competitive intelligence.

Earlier in his career, Anson was a senior licensing officer at the University of California, San Francisco Office of Technology Management, where he was responsible for managing and commercializing a portfolio of inventions, including those in the technical areas of diagnostics, disease therapeutics, immunology, infectious diseases, medical devices, medical software, molecular biology, and small molecule design.

As a scientist, Anson has conducted research across a broad range of biological and chemical disciplines, including protein structure, enzyme activity and regulation, small molecule modulators, virology, biophysics, and molecular biology. He studied under Charles Craik, PhD, and Volker Dötsch, PhD.